BANK OF AMERICA CORP /DE/ - TAYSHA GENE THERAPIES INC ownership

TAYSHA GENE THERAPIES INC's ticker is TSHA and the CUSIP is 877619106. A total of 60 filers reported holding TAYSHA GENE THERAPIES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of TAYSHA GENE THERAPIES INC
ValueSharesWeighting
Q3 2023$120,648
+520.2%
38,180
+29.7%
0.00%
Q2 2023$19,454
-82.2%
29,431
-78.5%
0.00%
Q1 2023$109,190
-4.1%
137,001
+172.0%
0.00%
Q4 2022$113,850
-15.0%
50,376
-27.5%
0.00%
Q3 2022$134,000
-45.5%
69,505
+5.2%
0.00%
Q2 2022$246,000
-47.1%
66,043
-7.4%
0.00%
Q1 2022$465,000
-35.2%
71,358
+15.8%
0.00%
Q4 2021$718,000
+18.1%
61,646
+88.7%
0.00%
Q3 2021$608,000
+17.6%
32,677
+34.0%
0.00%
Q2 2021$517,000
+71.8%
24,379
+64.1%
0.00%
Q1 2021$301,000
+73.0%
14,855
+126.6%
0.00%
Q4 2020$174,0006,5560.00%
Other shareholders
TAYSHA GENE THERAPIES INC shareholders Q2 2022
NameSharesValueWeighting ↓
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO 1,147,040$13,363,0006.07%
Sands Capital Ventures, LLC 724,873$8,445,0001.25%
Quantum Private Wealth, LLC 145,718$1,697,0000.64%
Nantahala Capital Management 1,456,147$16,964,0000.60%
Artal Group S.A. 1,040,882$12,126,0000.33%
Alphabet Inc. 640,882$7,466,0000.18%
TYBOURNE CAPITAL MANAGEMENT (HK) LTD 500,000$5,825,0000.17%
TimesSquare Capital Management, LLC 659,100$7,679,0000.07%
GSA CAPITAL PARTNERS LLP 40,885$476,0000.06%
Virtus ETF Advisers LLC 11,519$134,0000.05%
View complete list of TAYSHA GENE THERAPIES INC shareholders